- Summary on the U.S. Supreme Court’s Opinion on Rutledge v. PCMA Dec 10, 2020 WASHINGTON, DC (December 10, 2020) – Today, the United States Supreme Court issued its opinion in... read more
- Pharmacy Groups Say New Rebate Rule Does Not Do Enough to Support Patients Nov 24, 2020 WASHINGTON, DC (November 24, 2020) – Today the country’s leading pharmacy groups issued this statement on... read more
- NASP Supports the SAFE TO WORK ACT Jul 30, 2020 WASHINGTON DC, (July 30, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
- Pharmacy Groups tell HHS that Any Action on Rebate Rule Must Involve Fixing Pharmacy DIR Fees Jul 29, 2020 WASHINGTON, DC (July 29, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
- NASP Submits Comments to CMS Jul 23, 2020 WASHINGTON, DC (July 23, 2020) – The National Association of Specialty Pharmacy (NASP) recently submitted comments... read more
- NASP submits comments to CMS on CMS-1744-IFC Jun 01, 2020 WASHINGTON, DC (June 1, 2020) – Please click here to read NASP’s comments submitted Monday, June... read more
- More than ¼ of the House of Representatives Call for Pharmacy DIR Reform Action Now Apr 27, 2020 WASHINGTON, DC (April 27, 2020) – With the help of the National Association of Specialty Pharmacy,... read more
- BiPartisan Support for DIR Reform in Next Congressional Stimulus Bill Apr 14, 2020 WASHINGTON, DC (April 14, 2020) – A bipartisan group of House Members of Congress is leading... read more
- NASP submits Comments to CMS on the 2021 and 2022 Proposed Rule Apr 07, 2020 WASHINGTON, DC (April 7, 2020) – Please click here to read NASP’s comments submitted Monday, April... read more
- Pharmacists Call for New Action to Enhance COVID-19 Patient Care Mar 20, 2020 WASHINGTON, DC (March 20, 2020) – NASP joined major pharmacy organizations, representing the interests of pharmacists... read more